Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children

NCT02965404 ·Status: COMPLETED ·Phase: PHASE1

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS

NCT04258995 ·Status: COMPLETED ·Phase: PHASE2

Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

NCT00053495 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age

NCT03170609 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

NCT03239873 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

NCT00389103 ·Status: WITHDRAWN ·Phase: PHASE1

An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine

NCT06484686 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4

A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.

NCT07280858 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

NCT04941144 ·Status: COMPLETED

A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines

NCT02981836 ·Status: COMPLETED ·Phase: PHASE3

Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19

NCT04780035 ·Status: COMPLETED ·Phase: PHASE3

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women

NCT04766086 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus

NCT05460429 ·Status: UNKNOWN ·Phase: PHASE4

Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination

NCT05422508 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

NCT00857493 ·Status: COMPLETED ·Phase: PHASE2

A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults

NCT00026611 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19

NCT05233826 ·Status: COMPLETED ·Phase: PHASE1

Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

NCT05933278 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults

NCT01755689 ·Status: COMPLETED ·Phase: PHASE3

Dryvax Dilution-Prev Vacc Adults

NCT00032708 ·Status: COMPLETED ·Phase: PHASE2

A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19

NCT04672395 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

NCT04990544 ·Status: UNKNOWN ·Phase: PHASE2

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

NCT00430534 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat

NCT02474589 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

NCT01505647 ·Status: COMPLETED ·Phase: PHASE3